Disclosed is a pharmaceutical composition comprising a mixture of a basic granulate made of at least one pharmaceutically acceptable adjuvant, atorvastatin or rosuvastatin or pharmaceutically acceptable salts thereof, and other optional pharmaceutically acceptable adjuvants. Said pharmaceutical composition is characterized, inter alia, in that the active substance contained therein is stabilized in an amorphous or metastable crystalline form.
